HIF1A and non-small cell lung carcinoma: However, it is still unclear that if the plasma level of HIF-1α was tested by dynamic monitoring, whether the results can reflect the curative effect of NSCLC related treatment, whether the plasma level of HIF-1α can reflect the condition of the patients’ disease.